Carroll Patrick Harrison
Chief Medical Officer
Carroll Patrick Harrison has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Carroll Patrick Harrison is listed as Chief Medical Officer at Hims & Hers Health, Inc. Inside the rolling window, Carroll Patrick Harrison reported no open-market purchases and 2 open-market sales totaling $1.2M in HIMS. The largest disclosed transaction in the window is a sale of 23,726 HIMS shares on Jun 18, 2026, worth $830K.
Companies traded
Other insiders at HIMS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 17, 2025 | HIMS | Sale | $506K |
Frequently asked questions
How many SEC Form 4 filings has Carroll Patrick Harrison made?
Carroll Patrick Harrison has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Carroll Patrick Harrison trade?
Carroll Patrick Harrison has filed SEC Form 4 disclosures for 1 company, including HIMS.
When was Carroll Patrick Harrison's most recent SEC Form 4 filing?
Carroll Patrick Harrison's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Carroll Patrick Harrison's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Carroll Patrick Harrison is listed as Chief Medical Officer.
What is Carroll Patrick Harrison's total buy and sell value in the current window?
Inside the rolling retention window, Carroll Patrick Harrison bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Carroll Patrick Harrison's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,726 HIMS shares on 2026-06-18, worth $830K, per SEC Form 4 filings.